Funding to accelerate the development of a new, rapid molecular diagnostic testing system.
Feb. 19, 2013
/PRNewswire/ - Xagenic Inc., a privately held molecular diagnostics company, today announced that it will receive up to
in funding from the Government of
to support design and development of the first lab-free molecular diagnostic platform with a 20-minute time to result.
The Honourable Gary Goodyear, Minister of State for the Federal Economic Development Agency for
(FedDev Ontario), made the announcement in the keynote speech at the Conference Board of
Business Innovation Summit 2013 in
The Investing in Business Innovation initiative is designed to boost private sector investment in start-up businesses to accelerate the development of new products, processes and practices and bring them to market.
"This investment from FedDev complements our
Series A venture capital round, which included investments from CTI Life Sciences Fund, the Ontario Emerging Technologies Fund (OETF) and QIAGEN N.V.", said
, Chief Technology Officer of Xagenic. "In the current environment, financial support from the Government enhances our capabilities to develop cutting edge technologies that improve patient care," added the company's Director of Business Development,
About Xagenic Inc.
Xagenic Inc. is a
-based, venture backed start-up company developing the first lab-free molecular diagnostic platform with a 20-minute time to result. The company's fully automated technology platform will enable widespread decentralized diagnostic testing to be performed outside of clinical testing laboratories. Xagenic is developing infectious disease diagnostic tests that will allow the detection of a variety of analytes in situations where rapid test turnaround will provide clinically actionable results that dramatically improve patient care and reduce health care costs. More information on Xagenic can be found at
SOURCE Xagenic Canada Inc.